21q22.11q22.12 microdeletion syndrome

21q22.11q22.12 microdeletion syndrome is an extremely rare chromosomal disorder caused by a small (interstitial) deletion on the long arm of chromosome 21, specifically in the 22.11 to 22.12 cytogenetic bands. This region contains several genes that are important for normal development, and their loss leads to a recognizable pattern of clinical features. The syndrome is classified under partial monosomy of chromosome 21 (ICD-10: Q93.5) and is catalogued in Orphanet under code 261323. The condition primarily affects neurodevelopment, with intellectual disability and developmental delay being core features. Affected individuals may present with speech and language delays, behavioral difficulties, and variable degrees of cognitive impairment. Craniofacial dysmorphic features have been reported, which may include facial asymmetry, abnormal ear morphology, and other subtle but characteristic findings. Some patients may also exhibit growth abnormalities and skeletal or limb anomalies. Congenital anomalies affecting other organ systems, including the heart, have been described in some cases, though the phenotypic spectrum can vary depending on the exact size and gene content of the deletion. There is currently no cure or targeted therapy for 21q22.11q22.12 microdeletion syndrome. Management is supportive and multidisciplinary, focusing on early intervention programs including speech therapy, occupational therapy, physical therapy, and special educational support. Cardiac or other structural anomalies, if present, are managed according to standard clinical protocols. Genetic counseling is recommended for affected families to assess recurrence risk and to clarify whether the deletion arose de novo or was inherited from a carrier parent with a balanced chromosomal rearrangement.

Common questions about 21q22.11q22.12 microdeletion syndrome